BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23916966)

  • 1. A new method combining sequential immunoaffinity depletion and differential in gel electrophoresis to identify autoantibodies as cancer biomarkers.
    Grandjean M; Dieu M; Raes M; Feron O
    J Immunol Methods; 2013 Oct; 396(1-2):23-32. PubMed ID: 23916966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers.
    Grandjean M; Sermeus A; Branders S; Defresne F; Dieu M; Dupont P; Raes M; De Ridder M; Feron O
    PLoS One; 2013; 8(10):e76508. PubMed ID: 24130777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer immunomics: from serological proteome analysis to multiple affinity protein profiling.
    Hardouin J; Lasserre JP; Sylvius L; Joubert-Caron R; Caron M
    Ann N Y Acad Sci; 2007 Jun; 1107():223-30. PubMed ID: 17804550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients.
    Gagnon A; Kim JH; Schorge JO; Ye B; Liu B; Hasselblatt K; Welch WR; Bandera CA; Mok SC
    Clin Cancer Res; 2008 Feb; 14(3):764-71. PubMed ID: 18245537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Antibodies to Tumor-Associated Antigens.
    Álvarez-Fernández SM; De Monte L; Alessio M
    Methods Mol Biol; 2016; 1393():11-25. PubMed ID: 27033212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of melanoma antigens using a Serological Proteome Approach (SERPA).
    Suzuki A; Iizuka A; Komiyama M; Takikawa M; Kume A; Tai S; Ohshita C; Kurusu A; Nakamura Y; Yamamoto A; Yamazaki N; Yoshikawa S; Kiyohara Y; Akiyama Y
    Cancer Genomics Proteomics; 2010; 7(1):17-23. PubMed ID: 20181627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
    Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
    Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proteomic approach based on multiple parallel separation for the unambiguous identification of an antibody cognate antigen.
    Mun J; Kim YH; Yu J; Bae J; Noh DY; Yu MH; Lee C
    Electrophoresis; 2010 Oct; 31(20):3428-36. PubMed ID: 20872419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer.
    Lu H; Goodell V; Disis ML
    J Proteome Res; 2008 Apr; 7(4):1388-94. PubMed ID: 18311901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonality characterization of natural epitope-specific antibodies against the tumor-related antigen topoisomerase IIa by peptide chip and proteome analysis: a pilot study with colorectal carcinoma patient samples.
    Linnebacher M; Lorenz P; Koy C; Jahnke A; Born N; Steinbeck F; Wollbold J; Latzkow T; Thiesen HJ; Glocker MO
    Anal Bioanal Chem; 2012 Apr; 403(1):227-38. PubMed ID: 22349330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-dimensional immunoproteomics coupled with in vitro recapitulation of oncogenic NRAS
    Belousov PV; Afanasyeva MA; Gubernatorova EO; Bogolyubova AV; Uvarova AN; Putlyaeva LV; Ramanauskaite EM; Kopylov AT; Demin DE; Tatosyan KA; Ustiugova AS; Prokofjeva MM; Lanshchakov KV; Vanushko VE; Zaretsky AR; Severskaia NV; Dvinskikh NY; Abrosimov AY; Kuprash DV; Schwartz AM
    Cancer Lett; 2019 Dec; 467():96-106. PubMed ID: 31326556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
    Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q
    Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proteomics approach to find a new breast cancer-specific antigenic marker.
    Kobayashi R
    Clin Cancer Res; 2001 Nov; 7(11):3325-7. PubMed ID: 11705843
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary study of thyroid and colon cancers-associated antigens and their cognate autoantibodies as potential cancer biomarkers.
    Kiyamova R; Garifulin O; Gryshkova V; Kostianets O; Shyian M; Gout I; Filonenko V
    Biomarkers; 2012 Jun; 17(4):362-71. PubMed ID: 22612312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients.
    Gupta P; Suman S; Mishra M; Mishra S; Srivastava N; Kumar V; Singh PK; Shukla Y
    Proteomics Clin Appl; 2016 May; 10(5):564-73. PubMed ID: 27068564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer.
    Kim S; Cho H; Nam EJ; Kim SW; Kim YT; Park YW; Kim BW; Kim JH
    Genes Chromosomes Cancer; 2010 Jul; 49(7):585-95. PubMed ID: 20461751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.
    Abols A; Ducena K; Zayakin P; Silina K; Kalnina Z; Sadovska L; Tars J; Vilmanis J; Narbuts Z; Eglitis J; Pirags V; Line A
    Cancer Biomark; 2014; 14(5):361-9. PubMed ID: 25171478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera.
    Yang Z; Chevolot Y; Géhin T; Solassol J; Mange A; Souteyrand E; Laurenceau E
    Biosens Bioelectron; 2013 Feb; 40(1):385-92. PubMed ID: 23017679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins.
    Fabien N; Moreira A; Lavergne JP; Desbos A; Surgey P; Alves de Olivera C; Gonzalo P; Venot A; Bienvenu J; Perrier H; Reboud JP; Monier JC
    J Autoimmun; 1999 Aug; 13(1):103-10. PubMed ID: 10441174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.